Massachusetts Institute of Technology
Department of Biology Headquarters, Building 68-13
77 Massachusetts Avenue
Cambridge
Massachusetts
02139-4307
United States
Tel: 617-253-4701
Fax: 617-253-8699
Website: http://www.mit.edu/
Email: mitbiohq@mit.edu
About Massachusetts Institute of Technology
The mission of MIT is to advance knowledge and educate students in science, technology and other areas of scholarship that will best serve the nation and the world in the 21st century.
The Institute is committed to generating, disseminating and preserving knowledge, and to working with others to bring this knowledge to bear on the world's great challenges. MIT is dedicated to providing its students with an education that combines rigorous academic study and the excitement of discovery with the support and intellectual stimulation of a diverse campus community. We seek to develop in each member of the MIT community the ability and passion to work wisely, creatively and effectively for the betterment of humankind.
700 articles about Massachusetts Institute of Technology
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Cardiff Oncology in Collaboration with MIT Presents Gene Signature Analyses Data Identifying Androgen-Independent Mechanism for Onvansertib-Abiraterone Synergy in mCRPC
4/10/2021
Onvansertib and the androgen receptor (AR) signaling inhibitor abiraterone synergize in an AR-independent manner in in-vitro and in-vivo metastatic castrate-resistant prostate cancer (mCRPC) models
-
Orna Therapeutics Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies
2/24/2021
Synthetic circular RNA (oRNA) combines nature-driven insights with rational design to produce a bold new class of RNA therapeutics
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 8, 2020.
-
Prostate Cancer Foundation and MIT Researcher Develops Revolutionary Re-Useable Personal Protective Mask to Battle COVID-19
4/14/2020
To combat the short supply and high demand for the personal protective equipment (PPE) needed to safeguard medical professionals and first responders in the battle against the COVID-19 global crisis, Prostate Cancer Foundation (PCF) Young Investigator and Massachusetts Institute of Technology (MIT) researcher and physician, James Byrne, M.D., Ph.D., and his team have found an innovative way to arm heroes on the frontlines.
-
The Ragon Institute of MGH, MIT and Harvard Receives Gift from Nancy Zimmerman to Help Fund Development of Early Response COVID-19 Diagnostic
3/30/2020
The Ragon Institute of MGH, MIT and Harvard announced it has received a gift from Nancy Zimmerman to help fund development of an early response coronavirus diagnostic that would support medical and other front-line professionals and help manage the current pandemic.
-
The experimental patch monitors glucose levels and has doses of insulin pre-loaded in micro-needles.
-
A recent study questions if the FDA and other regulatory agencies worldwide rush certain approvals, particularly at the end of the year in a kind of “desk-clearing” activity.
-
The new facility, which could be open by the end of 2021, will be supported by Harvard University, Massachusetts Institute of Technology, GE Healthcare Life Sciences, Alexandria Real Estate Equities and FUJIFILM Diosynth Biotechnologies.
-
Standard International and Elysium Health™ Announce Science-Backed Wellness Partnership
10/30/2019
With a shared commitment to innovation, the alliance aims to support a healthier humanity--starting with healthier guests
-
More and better clinical trial data key to the personalization of treatment decisions for lung cancer patients
9/26/2019
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer
-
In Wake of Terminations, Pharma Leaders Decry Actions That Will Limit Collaborations with Foreign...
8/23/2019
Leaders from across the pharmaceutical industry are decrying negative actions taken by government agencies and universities against Chinese researchers in the United States. -
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
There is, thankfully, no age limit on innovation—you can do it at any age. But for many, “young,” counts as under 30, sometimes under 35, or even under 40, at least in terms of putting together lists of scientific innovators.
-
ERS Genomics Provides Comment on New Patent Interference With the Broad Institute Relating to Invention of the CRISPR/Cas9 System
6/26/2019
ERS Genomics Limited announced that the U.S. Patent and Trademark Office declared a patent interference between 10 separate patent applications owned by the University of California, the University of Vienna, and Dr. Emmanuelle Charpentier, on the one hand, and 13 patents and one application held by the Broad Institute, Harvard University, and the Massachusetts Institute of Technology.
-
In the last 80 years, the U.S. has become a powerhouse of science and technology, largely through concerted investment on the part of the government. In fact, that scientific investment drove the economy. But in recent years that investment has slipped, and many believe the U.S. is at risk of fal...
-
Recently published research by MIT neuroscientists indicates that amyloid plaques could be reduced via brain wave stimulation.
-
Research Roundup: Inactive Drug Ingredients, Whole-Body Regeneration Genes, Alzheimer’s Tests and...
3/22/2019
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
In the wake of the scandal caused by a Chinese researcher’s use of CRISPR-Cas9 gene editing to alter the DNA of embryos for seven couples, leading scientists called for a moratorium on heritable genome editing.